R2 Innovations, LLC is a Colorado-based, privately owned limited liability company founded in 1998. With a strong focus on research and development, the company has established partnerships with National Jewish Health and Rocky Mountain Poison & Drug Center. R2 Innovations is dedicated to developing and manufacturing cannabinoid-based medicines that address asthma, a chronic inflammatory disease of the airways.

Their product portfolio includes a range of innovative solutions, such as respiratory aerosols, sublingual treatments, and topicals. Leveraging their core competencies in research and discovery, bio-botanical formulation, and product development, R2 Innovations aims to provide natural relief for respiratory conditions. If you're interested in white label cannabidiol product development and manufacturing or licensed cannabis aerosol laboratories, you can contact them directly.

R2 Innovations is committed to delivering high-quality products and ensuring customer satisfaction, as evidenced by their prompt response to inquiries. Please note that the company's products have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease